1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Iterum Therapeutics PLC (ITRM)
  7. News

ITRM

Iterum Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Iterum Therapeutics PLC ITRM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0097 4.85% 0.2099 19:58:26
Open Price Low Price High Price Close Price Prev Close
0.2059 0.2007 0.228 0.2134 0.2002
more quote information »

Recent News

Date Time Source Heading
6/24/202218:01EDGARStatement of Changes in Beneficial Ownership (4)
6/24/202218:01EDGARStatement of Changes in Beneficial Ownership (4)
6/24/202218:01EDGARStatement of Changes in Beneficial Ownership (4)
6/24/202218:01EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:02EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:02EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:02EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:02EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:01EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202208:16EDGARCurrent Report Filing (8-k)
6/14/202217:00GLOBEIterum Therapeutics Reports Inducement Grant Under Nasdaq..
6/01/202217:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/16/202206:28TRMNH.C. Wainwright Sticks to Their Hold Rating for Iterum..
5/13/202207:32EDGARQuarterly Report (10-q)
5/13/202207:17EDGARCurrent Report Filing (8-k)
5/13/202207:00GLOBEIterum Therapeutics Reports First Quarter 2022 Financial..
5/11/202210:25TRMNH.C. Wainwright Sticks to Its Hold Rating for Iterum..
5/11/202208:00GLOBEIterum Therapeutics Provides Regulatory Update
4/25/202217:06GLOBEIterum Therapeutics Presented Data at the 32nd European..
4/25/202208:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/25/202207:31EDGARProxy Statement (definitive) (def 14a)
3/29/202206:26TRMNIterum Therapeutics (ITRM) Gets a Hold Rating from H.C...
3/28/202207:15EDGARCurrent Report Filing (8-k)
3/28/202207:02SEEKIterum Therapeutics GAAP EPS of -$0.02 beats by $0.02
3/28/202207:00GLOBEIterum Therapeutics Reports Fourth Quarter and Full Year..
3/22/202219:00EDGARStatement of Changes in Beneficial Ownership (4)
3/21/202208:00GLOBEIterum Therapeutics to Provide Business Update and Report..
3/15/202219:12EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
3/15/202217:02EDGARStatement of Changes in Beneficial Ownership (4)
3/15/202217:01EDGARStatement of Changes in Beneficial Ownership (4)
3/10/202208:00GLOBEIterum Therapeutics Granted 180-Day Extension by Nasdaq to..
2/08/202217:00GLOBEIterum Therapeutics Reports Inducement Grant Under Nasdaq..
1/03/202217:31EDGARAmended Statement of Ownership (sc 13g/a)
12/14/202116:30GLOBEIterum Therapeutics Reports Inducement Grant Under Nasdaq..
12/13/202108:00GLOBEIterum Therapeutics Appoints Sailaja Puttagunta, MD as Chief..
12/09/202109:18EDGARSecurities Registration: Employee Benefit Plan (s-8)
11/23/202104:09TRMNIterum Therapeutics (ITRM) Gets a Hold Rating from RBC..
11/12/202107:30EDGARCurrent Report Filing (8-k)
11/12/202107:07SEEKIterum Therapeutics EPS beats by $0.01
11/12/202107:00GLOBEIterum Therapeutics Reports Third Quarter 2021 Financial..
11/05/202107:00GLOBEIterum Therapeutics to Provide Business Update and Report..
9/30/202108:00PRNUSAntimicrobials Working Group Highlights Member Company..
9/28/202108:00GLOBEIterum Therapeutics Provides Update from FDA Type A Meeting..
9/28/202107:30GLOBEIterum Therapeutics to Present Data at IDWeek 2021
9/08/202108:55GLOBEIterum Therapeutics to Present at the H.C. Wainwright 23rd..
8/13/202107:32EDGARQuarterly Report (10-q)
8/13/202107:00GLOBEIterum Therapeutics Reports Second Quarter 2021 Financial..
8/06/202107:00GLOBEIterum Therapeutics to Provide Business Update and Report..
8/05/202108:00PRNUSAcurx Pharmaceuticals Joins the Antimicrobials Working Group
7/28/202110:04TRMNIterum: FDA Rejects UTI Treatment, What’s Next?
Your Recent History
NASDAQ
ITRM
Iterum The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220703 15:53:17